StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / adcentrx.com

Adcentrx Therapeutics

Adcentrx Therapeutics (adcentrx.com): 1 change recorded in its website history since September 2021. Homepage last checked 4 November 2026.

The website did not answer the latest live check. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. FundingBetween and

    Announced on its homepage: “Learn More Press Releases Latest News Adcentrx Announces Extension of Series A+ Financing to $51 Million December 5, 2023 Menu”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 20 September 2021

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Merging CHEMISTRY AND BIOLOGY TO BENEFIT THE LIVES OF PATIENTS

Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. Contact us.

Homepage

Compliance claims on the website
FDA-APPROVED

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. September 2021 – November 2026 · 14 captures · latest observed messagingMerging chemistry & biology to benefit the lives of patients

    Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases.

    This wording observed 4 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 14 captures in this group
    • 20 September 2021 · Merging CHEMISTRY AND BIOLOGY TO BENEFIT THE LIVES OF PATIENTS archived page
    • 16 January 2022 · Merging CHEMISTRY AND BIOLOGY TO BENEFIT THE LIVES OF PATIENTS archived page
    • 23 July 2022 · Merging CHEMISTRY AND BIOLOGY TO BENEFIT THE LIVES OF PATIENTS archived page
    • 2 February 2023 · Merging chemistry & biology to benefit the lives of patients archived page
    • 22 September 2023 · Merging chemistry & biology to benefit the lives of patients archived page
    • 4 January 2024 · Merging chemistry & biology to benefit the lives of patients archived page
    • 21 July 2024 · Merging chemistry & biology to benefit the lives of patients archived page
    • 28 January 2025 · Merging chemistry & biology to benefit the lives of patients archived page
    • 8 July 2025 · Merging chemistry & biology to benefit the lives of patients archived page
    • 2 August 2025 · Merging chemistry & biology to benefit the lives of patients archived page
    • 6 August 2025 · Merging chemistry & biology to benefit the lives of patients archived page
    • 10 August 2026 · Merging chemistry & biology to benefit the lives of patients archived page
    • 8 September 2026 · Merging chemistry & biology to benefit the lives of patients archived page
    • 4 November 2026 · Merging chemistry & biology to benefit the lives of patients current websiteHistorical capture not publicly available

Cite this record

StartupHistory, “Adcentrx Therapeutics” company record, https://startuphistory.org/c/adcentrx.com

Machine-readable: /c/adcentrx.com.json. How changes are found: method.